Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy

International Journal of Cardiology

Volumn 94, Issue 1, 2004, Pages 31-34

  Dimitrow, P Petkow ^a   Podolec, P ^a   Grodecki, J ^a   Plazak W ^a   Dudek, D ^a   Pieniazek P ^a   Bacior, B ^a   Legutko, J ^a   Olszowska, M ^a   Kostkiewicz, M ^a   Kawecka Jaszcz, K ^a   Tracz, W ^a   Dubiel, J S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Gradient; Hypertrophic cardiomyopathy; Treatment

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE PACING; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HEMODYNAMIC MONITORING; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERMETHOD COMPARISON; MALE; MORPHOLOGY; PRIORITY JOURNAL; REMISSION;

CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HEART SEPTUM; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 12144290719     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.03.010     Document Type: Article

References (28)

1. Jeanrenaud X., Goy J.J., Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet. 339:1992;1318-1323.
2. Fananapazir L., Epstein N.D., Curiel R.et al. Long-term results of dual-chamber (dual chamber) pacing in obstructive hypertrophic cardiomyopathy. Circulation. 90:1994;2731-2742.
3. Kappenberger L., Linde C., Daubert C.et al. Pacing in hypertrophic obstructive cardiomyopathy. Eur. Heart J. 18:1997;1249-1256.
4. Maron B.J., Nishimura R.A., McKenna W.J.et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind, crossover study (M.-PATHY). Circulation. 99:1999;2927-2933.
5. Dimitrow P.P., Grodecki J., Bacior B.et al. The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy. PACE. 23:2000;1234-1239.
6. Sigwart U. Nonsurgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 346:1995;211-214.
7. Knight C., Kurbaan A.S., Seggewiss H.et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 95:1997;2075-2081.
8. Gietzen F., Leuner Ch., Gerenkamp Th. et al. Relief of obstruction in hypertrophic cardiomyopathy by transient occlusion of the first septal branch of the left coronary artery (abstract). Eur. Heart J. 15(Abstract Suppl.):1994;125.
9. Kuhn H., Gietzen F., Leuner Ch. et al. Induction of subaortic septal ischemia to reduce obstruction in hypertrophic obstructive cardiomyopathy: studies to develop a new catheter-based concept of treatment. Eur. Heart J. 18:1997;846-851.
10. Seggewiss H., Gleichmann U., Faber L.et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-months follow-up in 25 patients. J. Am. Coll. Cardiol. 31:1998;252-258.
11. Faber L., Seggewiss H., Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Circulation. 98:1998;2415-2421.
12. Gietzen F., Leuner Ch., Raute-Kreinsen U.et al. Acute and long-term results after transcoronary ablation of septal hypertrophy. Eur. Heart J. 20:1999;1342-1354.
13. Lakkis N.M., Nagueh S.F., Kleiman N.S.et al. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 98:1998;1750-1755.
14. Kuhn H., Gietzen F., Breithardt G.et al. Pacemaker therapy and alcohol ablation for hypertrophic obstructive cardiomyopathy: a randomized study (abstract). Eur. Heart J. 22(Abstract Suppl.):2001;175.
15. Roberts R., Sigwart U. New concepts in hypertrophic cardiomyopathy. Part II. Circulation. 104:2001;2249-2252.
16. Kizilbash A.M., Heinle S.K., Gayburn P.A. Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy. Circulation. 97:1998;461-466.
17. Tokiwa F., Tanaka Y., Sannou K.et al. Circadian variation of left ventricular outflow tract pressure gradient in hypertrophic obstructive cardiomyopathy (abstract). Circulation. 100(Abstract Suppl.):1999;4552.
18. Nishimura R.A., Hayes D.L., Ilstrup D.M.et al. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopthy. J. Am. Coll. Cardiol. 27:1996;421-430.
19. Panza J.A., Petrone R.K., Fananapazir L.et al. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 19:1992;91-99.
20. Faber L., Meisser A., Ziemssen P.et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients. Heart. 83:2000;326-331.
21. Mazur W., Nagueh S.F., Lakkis N.M.et al. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 103:2001;1492-1496.
22. Report of World Health Organization/International Society and Federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation. 93:1996;841-842.
23. Maron B.J., Epstein S.E. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am. J. Cardiol. 43:1979;1242-1244.
24. Schiller N.B., Shah P.M., Crawford M.H.et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J. Am. Soc. Echocardiogr. 2:1989;358-367.
25. Rużyllo W., Chojnowska L., Demkow M.et al. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy. Eur. Heart J. 21:2000;770-777.
26. Dudek D., Gil R., Dimitrow P.P.et al. Balloon positioning difficulties during nonsurgical septal reduction therapy in patient with hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc. Interv. 49:2000;314-317.
27. Gietzen F., Leuner Ch., Hegselmann J.et al. Haemodynamic effects of adjacent dual chamber-pacing in patients with high-grade atrioventricular block after transcoronary ablation of septum hypertrophy for hypertrophic obstructive cardiomyopathy (abstract). Eur. Heart J. 20(Abstract Suppl.):1999;463.
28. Marian A.J. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopath. Lancet. 355:2000;58-60.